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Since 1979, when a worldwide campaign 
succeeded in eradicating the pox, there 
have been no natural cases of smallpox.  In 
recent decades children have not been 
vaccinated against smallpox and the 
immunity of adults vaccinated as children 
has likely worn oﬀ.  	

However, because of its potential as a weapon of 
bioterrorism, smallpox has again become a topic of 
government and media interest and—for some—a 
public concern. 	

An abundance of social and health-related issues are 
raised by threat of the disease and also by risks 
associated with its vaccine.   	

The Environmental Risk Analysis Program is 
developing  a web-based guide to help Extension 
Educators navigate through these potentially 
confusing and controversial issues. 	

Smallpox—The Disease & Vaccine  
A “Guide to Issues” for CCE Educators	

<http://environmentalrisk.cornell.edu/C&ER/Smallpox>	

Lois Levitan, Ph.D., Program Leader	

Sara Miller, Undergraduate Intern	

Environmental Risk Analysis Program 
Cornell Department of Communication	

Funding provided by Cornell Cooperative Extension (CCE) as part of a USDA Cooperative State Research, 
Education and Extension Service (CSREES) Smith-Lever fund award for the project Helping Communities Learn 
to Deal with Environmental Risks, and USDA Extension Service special project award 2002-41210-01442.!
The Organism:  
Variola Pox Virus	

•  Large, brick-shaped, about  
size of small  bacteria	

Disease Symptoms	

•  Incubation: 1-2+ weeks. No  
symptoms.  Not infective	

•  Pre-Eruption (days 1-3): flu-like symptoms	

•   Lesions, Papules, Pustules (days 4-10): 
increasingly infective via aerosol	

•  Scabbing, Crusting (days 11-14): somewhat 
infective until all scabs gone 	
Day 10	

•  Patient dead or recovered w/in month	

•  Historically killed 3-4 million per year	

•   Children & elderly most susceptible  
(10% of those born, died)	

•  Mortality rate nearly 30%	

•  Most survivors scarred (~ 75%), many blind	

Disease Outcomes	

•  Dr. Edward Jenner in 1796 discovered 
benefits of injecting people with 
Vaccinia virus (cowpox) as protection 
against smallpox	

•  Live vaccine—derived from fluid 
scraped from sores on skin of  
 infected calves—poses its own  
risk of illness and contagion	

Community responsibility:  
Vaccines among top 10 public health 
achievements of 20th century (CDC)	

The Disease	

The Vaccine	

Smallpox Vaccine	

Experimental Design: 
James Phipps, 8-year-old son of Jenner’s gardener, was inoculated 
with cowpox, given 8 weeks to develop antibodies for resistance, & 
then exposed to smallpox. Success! — No infection!	

Civil liberties? Medical ethics?	
The Weapon	

•   Current attention to smallpox primarily  
 because of threat of use in germ warfare	

•   Risk diﬃcult to assess  
because uncertainty  is huge	

BioTerrorism	

•  US public does not trust any single  
spokesperson re: bioterrorism	

•  Nearly 3 in 10 African Americans 
believe there would be discrimination 
in treatment during an outbreak	

(Source: Harvard Public Health NOW. 
June 2002)	

Vaccination Strategies	
 Ring Vaccination Strategy  
(Surveillance/Containment)	

 This strategy relies on:  
• surveillance to identify everyone with smallpox (who informs?),  
• cooperation of the infected to identify all of their contacts who may have been exposed  
• cooperation of the exposed to be vaccinated & remain under surveillance/  
   possible quarantine,  
• cooperation in maintaining segregation between exposed & unexposed individuals 
   who have not been vaccinated,  
• support of community to support livelihoods and well-being of those under quarantine.	

Mass Vaccination  
                     Strategy	

As a precaution, vaccinate 80-100%, without distinguishing  
 between those who have (or are likely to be) exposed &  
others. !
